David, Kristin M <br/><br/>
Mycophenolate mofetil vs. azathioprine is associated with decreased acute rejection, late acute rejection, and risk for cardiovascular death in renal transplant recipients with pre-transplant diabetes.  [electronic resource] 

 -  Clinical transplantation  Apr 2005 
 - 279-85 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>0902-0063 
<br/><br/><label>Standard No.: </label>10.1111/j.1399-0012.2005.00338.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Azathioprine--therapeutic use<br/>Black People--statistics & numerical data<br/>Cause of Death<br/>Diabetes Complications--epidemiology<br/>Female<br/>Graft Rejection--epidemiology<br/>Graft Survival<br/>Heart Diseases--epidemiology<br/>Humans<br/>IMP Dehydrogenase--antagonists & inhibitors<br/>Immunosuppressive Agents--therapeutic use<br/>Infections--epidemiology<br/>Kidney Transplantation--statistics & numerical data<br/>Male<br/>Middle Aged<br/>Mycophenolic Acid--analogs & derivatives<br/>Neoplasms--epidemiology<br/>Survival Rate<br/>United States--epidemiology<br/>White People--statistics & numerical data<br/>Black or African American